Evidence map›Paper›PMID 40753082›Full record

ArticleNature communications2025

Melanin-like nanofibers with highly ordered structures achieve ultrahigh specific electromagnetic interference shielding efficiency.

Peng Chen, Shibo He, Tianyou Wang, Chencan Wang, Junru Tao, Yiwen Li

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peng ChenCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, 610065, Chengdu, China.
Shibo HeCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, 610065, Chengdu, China.
Tianyou WangCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, 610065, Chengdu, China.
Chencan WangCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, 610065, Chengdu, China.
Junru TaoCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, 610065, Chengdu, China.
Yiwen LiCollege of Polymer Science and Engineering, State Key Laboratory of Advanced Polymer Materials, Sichuan University, 610065, Chengdu, China. ywli@scu.edu.cn.ORCID http://orcid.org/0000-0002-6874-0350

Funding

National Natural Science Foundation of China (National Science Foundation of China) 52225311
6 · The paper itself

Abstract

Lightweight, high-performance electromagnetic shielding materials rely on the precise design of electromagnetic response structures. Conventional shielding materials often involve complex fabrication of conjugated composites or graphitization of organic materials, facing challenges in balancing their performance and processability. As such, seeking and designing intrinsically conjugated materials with superior processability is crucial. In this work, we have innovatively engineered those bioinspired polymers with highly ordered microstructures, using a 5, 6-dihydroxyindole ring tetramer framework to construct highly ordered melanin-like nanofibers by tuning π-π stacking. The resulting melanin-like aerogels represent surprising microwave absorption performance, a maximum reflection loss of -68.87 dB, and an effective absorption bandwidth of 5.25 GHz. In the X-band, the aerogel reached the specific EMI shielding efficiency of 47909.9 dB cm

Identifiers

PMID40753082
PMCPMC12318055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.